These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17646422)

  • 21. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients.
    Cesaro S; Giacchino M; Locatelli F; Spiller M; Buldini B; Castellini C; Caselli D; Giraldi E; Tucci F; Tridello G; Rossi MR; Castagnola E
    BMC Infect Dis; 2007 Apr; 7():28. PubMed ID: 17442100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.
    Viscoli C; Herbrecht R; Akan H; Baila L; Sonet A; Gallamini A; Giagounidis A; Marchetti O; Martino R; Meert L; Paesmans M; Ameye L; Shivaprakash M; Ullmann AJ; Maertens J;
    J Antimicrob Chemother; 2009 Dec; 64(6):1274-81. PubMed ID: 19841031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosis.
    Würthwein G; Cornely OA; Trame MN; Vehreschild JJ; Vehreschild MJ; Farowski F; Müller C; Boos J; Hempel G; Hallek M; Groll AH
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1664-71. PubMed ID: 23335740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oesophageal aspergillosis in a case of acute lymphoblastic leukaemia successfully treated with caspofungin alone due to liposomal amphotericin B induced severe hepatotoxicity.
    Akyol Erikci A; Ozyurt M; Terekeci H; Ozturk A; Karabudak O; Oncu K
    Mycoses; 2009 Jan; 52(1):84-6. PubMed ID: 18498301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
    Ament AJ; Hübben MW; Verweij PE; de Groot R; Warris A; Donnelly JP; van 't Wout J; Severens JL
    J Antimicrob Chemother; 2007 Aug; 60(2):385-93. PubMed ID: 17561501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiences with the use of caspofungin in paediatric patients.
    Lehrnbecher T; Groll AH
    Mycoses; 2008; 51 Suppl 1():58-64. PubMed ID: 18471162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of innate immune receptors in paradoxical caspofungin activity in vivo in preclinical aspergillosis.
    Moretti S; Bozza S; D'Angelo C; Casagrande A; Della Fazia MA; Pitzurra L; Romani L; Aversa F
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4268-76. PubMed ID: 22644025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.
    Castagnola E; Moresco L; Cappelli B; Cuzzubbo D; Moroni C; Lanino E; Faraci M
    J Chemother; 2007 Jun; 19(3):339-42. PubMed ID: 17594932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of subcutaneously disseminated aspergillosis with caspofungin acetate in an allogeneic peripheral blood stem cell transplantation patient.
    Chamuleau ME; Deenik W; Zweegman S; Jonkhoff AR; Zaaijer HL; Janssen JJ
    Haematologica; 2003 Apr; 88(4):ECR10. PubMed ID: 12681983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis.
    Keir GJ; Garfield B; Hansell DM; Loebinger MR; Wilson R; Renzoni EA; Wells AU; Maher TM
    Thorax; 2014 Mar; 69(3):287-8. PubMed ID: 24029745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy.
    Kabbara N; Lacroix C; Peffault de Latour R; Socié G; Ghannoum M; Ribaud P
    Haematologica; 2008 Apr; 93(4):639-40. PubMed ID: 18379015
    [No Abstract]   [Full Text] [Related]  

  • 32. Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation.
    Pancham S; Hemmaway C; New H; Albert E; Dokal I; Roberts IA; McCloy M
    Pediatr Transplant; 2005 Apr; 9(2):254-7. PubMed ID: 15787803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.
    Klont RR; Mennink-Kersten MA; Ruegebrink D; Rijs AJ; Blijlevens NM; Donnelly JP; Verweij PE
    Clin Infect Dis; 2006 Aug; 43(3):e23-5. PubMed ID: 16804836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of a transjugular intrahepatic portosystemic shunt on the pharmacokinetics of caspofungin in a critically ill patient.
    Spriet I; Meyfroidt G; Maleux G; Verslype C; Willems L
    Pharmacology; 2012; 90(5-6):247-50. PubMed ID: 23007631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on echinocandin antifungals.
    Kauffman CA; Carver PL
    Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain Abscesses Due to Aspergillus nidulans Infection During Induction Chemotherapy for Acute Lymphoblastic Leukemia.
    Sadarangani M; Harvey M; McDonald A; Speert DP; Dix D
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):e384-6. PubMed ID: 25985238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive esophageal aspergillosis associated with acute myelogenous leukemia: successful therapy with combination caspofungin and liposomal amphotericin B.
    Alioglu B; Avci Z; Canan O; Ozcay F; Demirhan B; Ozbek N
    Pediatr Hematol Oncol; 2007; 24(1):63-8. PubMed ID: 17130115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress in combination therapy for invasive aspergillosis].
    Luo L; Tong Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):41-4. PubMed ID: 24694973
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacology and clinical use of caspofungin.
    Hope WW; Shoham S; Walsh TJ
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):263-74. PubMed ID: 17428155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspofungin for treatment of invasive aspergillus infections.
    Heinz WJ; Einsele H
    Mycoses; 2008; 51 Suppl 1():47-57. PubMed ID: 18471161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.